TABLE 2.

Clinical features, HBV genotypes, HBV DNA levels, and liver inflammation in relation to HBeAg and clinical status

HBeAg and clinical status	No. of patients	Age (yr)	Sex (no. of males:no. of females)	No. infected with genotype B:no. infected with genotype C	ALT level (U/liter)	HBV DNA concn (log pg/ml)	HAI inflammation score	HAI fibrosis score
HBeAg positive
Asymptomatic carriers	28	31.6 ± 8.9	13:15	20:8	25.3 ± 13.2
Chronic hepatitis patients	59	34 ± 10.0a	45:14	37:19	201.9 ± 169.5	2.8 ± 1.0c	6.4 ± 3.7	0.8 ± 1.1
Liver cirrhosis patients	16	44.4 ± 12	15:1	4:12	87.5 ± 58.6	2.0 ± 1.2d	6.4 ± 4.5	4
Subtotal	103	35 ± 10.8b	73:30	61:39	136.1 ± 152.1	2.6 ± 1.1e	6.4 ± 3.8	1.5 ± 1.6f
HBeAg negative
Asymptomatic carriers	38	31.7 ± 11.3	22:16	32:6	22.8 ± 9.9
Chronic hepatitis patients	36	40.5 ± 12.1a	31:5	28:8	161.5 ± 212.9	1.7 ± 1.0c	5.6 ± 3.4	0.9 ± 1.2
Liver cirrhosis patients	23	45.8 ± 12	18:5	10:13	147.4 ± 154.6	1.3 ± 1.0d	6.4 ± 2.5	4
Subtotal	97	38.4 ± 12.9b	71:26	70:27	103.8 ± 162.3	1.5 ± 1.0e	5.9 ± 3.1	2.1 ± 1.8f

^aP = 0.0056.

^bP < 0.001.

^cP < 0.001.

^dP = 0.057.

^eP < 0.001.

^fP = 0.044.